搜索临床试验以:SHR-3032 安慰剂
总计55597个结果
-
Jiangsu HengRui Medicine Co., Ltd.主动,不招人
-
Selecta Biosciences, Inc.National Human Genome Research Institute (NHGRI)暂停
-
Eli Lilly and Company完全的A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis (IXORA-S)斑块状银屑病德国, 西班牙, 比利时, 法国, 匈牙利, 奥地利, 加拿大, 意大利, 荷兰, 波兰, 瑞典, 瑞士, 英国
-
University of Alabama at BirminghamNational Cancer Institute (NCI)主动,不招人
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.招聘中
-
Tianjin Medical University Cancer Institute and...Jiangsu HengRui Medicine Co., Ltd.完全的
-
Herbert Hurwitz, MDGlaxoSmithKline; National Comprehensive Cancer Network; Threshold Pharmaceuticals完全的
-
Fudan UniversityShanghai Shen Kang Hospital Development Center招聘中
-
Shanghai Chest Hospital尚未招聘
-
Aker Biomarine Antarctic ASAmpel BioSolutions, LLC完全的
-
The First Affiliated Hospital of Zhengzhou University招聘中
-
AbbVie招聘中
-
Janssen Research & Development, LLC完全的
-
TetraLogic PharmaceuticalsPPD; The Leukemia and Lymphoma Society; Veristat, Inc.; Therapeutics, Inc.完全的
-
Jiangsu HengRui Medicine Co., Ltd.招聘中
-
Pamela Munster撤销晚期实体瘤 | 脑转移 | 记录在案的 Her2 过度表达 | 神经稳定
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu HengRui Medicine Co., Ltd.完全的
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu HengRui Medicine Co., Ltd.完全的
-
Jiangsu HengRui Medicine Co., Ltd.招聘中
-
Threshold Pharmaceuticals未知